Company intelligence / Profile preview

Series X Capital

California, United Statesadviserinfo.sec.gov ↗

Ownership: Private
Development stage: Other

Overview

Series X Capital is a venture capital fund established in 2024 to support the spin-off and growth of companies emerging from Alphabet’s X Lab. The fund focuses on providing initial funding for new independent enterprises created from ambitious projects at the lab, such as Waymo and Verily. It has already invested in supply chain and telecommunications startups spun out of the lab and is evaluating further opportunities across various sectors. Alphabet remains a limited partner with minority stakes in these spin-offs. There are no clinical results or drug development programs associated with Series X Capital.

Industry: Investors

Partnerships

Alphabet/X Lab partnership as primary source of deal flow

Beyond the preview

Go deeper on Series X Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Series X Capital.

Explore the full profile